In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time‐of‐flight mass spectrometry

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2018-05-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jpba.2018.02.032PMID 29494888
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The emergence of new psychoactive substance (NPS) benzodiazepines: A review.

  2018cited by this paper
• Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5‐MAPB, and 5‐API as examples

  2017cited by this paper
• Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples

  2017influential reference
• Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples

  2017cited by this paper
• Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes

  2016cited by this paper
• Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.

  2016influential reference
• In vitro Phase I and Phase II metabolism of alpha-pyrrolidinovalerophenone ( alpha-PVP ) , methylenedioxypyrovalerone ( MDPV ) and methedrone by human liver microsomes and human liver cytosol Reference :

  2016cited by this paper
• Identification of in vitro metabolites of ethylphenidate by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

  2016cited by this paper
• Stereoselective Metabolism of α-, β-, and γ-Hexabromocyclododecanes (HBCDs) by Human Liver Microsomes and CYP3A4.

  2016cited by this paper
• Identification of in vitro and in vivo human metabolites of the new psychoactive substance nitracaine by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry

  2016cited by this paper
• In Vitro Drug Metabolism Using Liver Microsomes

  2016cited by this paper
• In vitro metabolism of 2-ethylhexyldiphenyl phosphate (EHDPHP) by human liver microsomes.

  2015cited by this paper
• In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol

  2015cited by this paper
• Novel psychoactive substances of interest for psychiatry

  2015cited by this paper
• New Psychoactive Substances in Europe. An Update from the EU Early Warning System

  2015cited by this paper
• Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.

  2015cited by this paper
• Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

  2015influential reference
• National Institute for Health and Care Excellence.

  2015cited by this paper
• Designer benzodiazepines: A new challenge

  2015cited by this paper
• Identifying small molecules via high resolution mass spectrometry: communicating confidence.

  2014cited by this paper
• The new drug phenomenon.

  2014cited by this paper
• First insights in the metabolism of phosphate flame retardants and plasticizers using human liver fractions.

  2013cited by this paper
• EURYDICE (2013): Key data on teachers and school leaders in Europe. 2013 edition Eurydice report (Luxembourg Publications Office of the European Union)

  2013cited by this paper
• Appendix: Drug Metabolizing Enzymes and Biotransformation Reactions

  2012cited by this paper
• Prolonged excretion of 7-aminoclonazepam in urine after repeated ingestion of clonazepam: a case report.

  2012cited by this paper
• Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).

  2011cited by this paper
• MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data

  2010cited by this paper
• Metabolism of diazepam and related benzodiazepines by human liver microsomes

  2010cited by this paper
• Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules.

  2010cited by this paper
• Disposition of Toxic Drugs and Chemicals in Man, 8th ed

  2009cited by this paper
• Sexual assaults facilitated by drugs or alcohol

  2009cited by this paper
• Benzodiazepine metabolism: an analytical perspective.

  2008cited by this paper
• Clonazepam in the treatment of psychiatric disorders: an update

  2006cited by this paper
• Use of Alcohol and Drugs to Self-Medicate Anxiety Disorders in a Nationally Representative Sample

  2006cited by this paper
• Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC-MS/MS. Application to forensic cases of drug facilitated crimes.

  2004influential reference
• Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam

  2003cited by this paper
• Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.

  2001cited by this paper
• Present and future in vitro approaches for drug metabolism.

  2000cited by this paper
• Liquid chromatography/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds

  2000cited by this paper
• In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

  2000cited by this paper
• Biopharmacological data and high-performance liquid chromatographic analysis of 1,4-benzodiazepines in biological fluids: a review.

  1992cited by this paper
• Quantitation of clonazepam and its 7-amino and 7-acetamido metabolites in plasma by high-performance liquid chromatography.

  1984cited by this paper
• Nitroreduction of clonazepam in human foetal liver microsomes and hepatocyte cultures.

  1984cited by this paper
• Disposition of toxic drugs and chemicals in man

  1982influential reference
• Concentrations of N-descyclopropylmethylprazepam in whole-blood, plasma, and milk after administration of prazepam to humans.

  1981cited by this paper
• Single‐Dose Kinetics of Prazepam, a Precursor of Desmethyldiazepam

  1979cited by this paper
• Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.

  1974cited by this paper
• Studies on nitrazepam reduction in vitro.

  1970cited by this paper

• Integrated chemical composition, transcriptomics, and network pharmacology to reveal the mechanism of Jia-Wei-Si-Miao-Yong-An Decoction in ACS model rats.

  2025cites this paper
• In Vitro Metabolism of Quaternary Ammonium Compounds and Confirmation in Human Urine by Liquid Chromatography Ion-Mobility High-Resolution Mass Spectrometry.

  2024cites this paper
• In vitro biotransformation of 3-methylmethcathinone (3-MMC) through incubation with human liver microsomes and cytosol and application to in vivo samples.

  2024cites this paper
• The use of prodrugs as drugs of abuse

  2024cites this paper
• Untargeted metabolomics analysis assisted by signal selection for comprehensively identifying metabolites of new psychoactive substances: 4-MeO-α-PVP as an example

  2023cites this paper
• New psychoactive substances—Designer benzodiazepines

  2021cites this paper
• In vitro Phase I metabolism of newly identified plasticizers using human liver microsomes combined with high resolution mass spectrometry and based on non-targeted and suspect screening workflows.

  2021cites this paper
• Obesity influences the microbiotic biotransformation of chlorogenic acid.

  2021cites this paper
• Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs

  2021cites this paper
• ‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports

  2020influential citation
• Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive Substances.

  2020cites this paper
• Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts

  2020cites this paper
• Human phase I in vitro liver metabolism of two bisphenolic diglycidyl ethers BADGE and BFDGE.

  2020cites this paper
• Kinetics and biotransformation products of bisphenol F and S during aerobic degradation with activated sludge.

  2020cites this paper
• Simulated Gastrointestinal Biotransformation of Chlorogenic Acid, Flavonoids, Flavonolignans and Triterpenoid Saponins in Cecropia obtusifolia Leaf Extract

  2020cites this paper
• Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

  2020cites this paper
• Toxicometabolomics of cathinone derivatives

  2020cites this paper
• Photochemical degradation of BPF, BPS and BPZ in aqueous solution: Identification of transformation products and degradation kinetics.

  2019cites this paper
• An expanding world of new psychoactive substances-designer benzodiazepines.

  2019cites this paper
• Investigating the in vitro metabolism of the dental resin monomers BisGMA, BisPMA, TCD-DI-HEA and UDMA using human liver microsomes and quadrupole time of flight mass spectrometry.

  2019cites this paper
• Identification and structural characterization of febuxostat metabolites in rat serum and urine samples using UHPLC-QTOF/MS.

  2019cites this paper
• Optimization of an in vitro gut microbiome biotransformation platform with chlorogenic acid as model compound: From fecal sample to biotransformation product identification.

  2019cites this paper
• Current-use of developers in thermal paper from 14 countries using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

  2019cites this paper
• Microwave-assisted synthesis of 11-substituted-3,3-dimethyl-2,3,4,5,10,11-hexahydrodibenzo[b,e][1,4]diazepin-1-one derivatives catalysed by silica supported fluoroboric acid as potent antioxidant and anxiolytic agents

  2019cites this paper
• Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non‐conventional biological matrices

  2019cites this paper
• Designer Benzodiazepines: Another Class of New Psychoactive Substances.

  2018cites this paper
• New benzodiazepines for sedation.

  2018cites this paper
• Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.

  2018cites this paper
• Bioanalytical studies of designer benzodiazepines

  2018influential citation
• The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects

  2018influential citation
• Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism.

  2018cites this paper